Postmortem study of ataxia with retinitis pigmentosa by mutation of the α-tocopherol transfer protein gene

A new syndrome of ataxia and retinitis pigmentosa with vitamin E deficiency caused by the missense mutation of α-tocopherol transfer protein (α-TTP) gene was recently proposed. After studying the first postmortem case with this mutation pathologically and biochemically, whether the symptoms can be t...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurology, neurosurgery and psychiatry Vol. 68; no. 4; pp. 521 - 525
Main Authors Yokota, T, Uchihara, T, Kumagai, J, Shiojiri, T, Pang, J J, Arita, M, Arai, H, Hayashi, M, Kiyosawa, M, Okeda, R, Mizusawa, H
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd 01.04.2000
BMJ
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new syndrome of ataxia and retinitis pigmentosa with vitamin E deficiency caused by the missense mutation of α-tocopherol transfer protein (α-TTP) gene was recently proposed. After studying the first postmortem case with this mutation pathologically and biochemically, whether the symptoms can be treated by supplementation of vitamin E or not is discussed. The major pathological findings were retinal atrophy; severe dying back-type degeneration of the posterior column; and massive accumulation of lipofuscin in neurons including dorsal root ganglion (DRG) cells, which were almost identical to those in vitamin E deficient animals and patients with fat malabsorption. Also, mild loss of Purkinje cells was noted. Because robust expression of α-TTP was detected in the cerebellum as well as in the liver and the tissue concentration of vitamin E in the cerebellum was still low even after oral supplementation, the mild Purkinje cell loss might be related to the mutant α-TTP in the cerebellum. By contrast, in the DRG, thought to be mainly responsible for ataxia, no expression of α-TTP was detected, and the tissue concentration of vitamin E increased to normal after supplementation. It is therefore considered that oral supplementation of vitamin E should effectively counteract the progression of ataxia.
Bibliography:PMID:10727494
istex:BD438C533546109D3D1CA19A654E68634FB662AC
ark:/67375/NVC-LB2CBQH8-Z
href:jnnp-68-521.pdf
local:jnnp;68/4/521
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0022-3050
1468-330X
DOI:10.1136/jnnp.68.4.521